CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (unaudited) (USD $)	6 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Cash flows from operating activities:
Net loss	$ (3,953,787)	$ (3,942,765)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	197,081	184,716
Fair value of vested options issued to officers, directors and employees	1,174,778	305,769
Amortization of capitalized financing costs	85,975	460,363
Amortization of debt discount attributable to convertible debentures	541,120	986,387
Equity based compensation	58,238	454,582
Common stock issued in settlement of interest	507,939	32,000
Changes in operating assets and liabilities:
Increase in accounts receivable	(115,056)	(36,209)
Decrease in prepaid expenses and deposits	39,954	93,839
Decrease in accounts payable and accrued liabilities	(379,829)	(29,047)
Net cash used in operating activities	(1,843,587)	(1,490,365)
Cash flows from investing activities:
Purchase of property and equipment	(47,133)
Net cash used in investing activities	(47,133)
Cash flows from financing activities:
Net proceeds from (payments of) related party advances		(50,000)
Net proceeds from issuance of convertible notes		1,645,500
Net cash provided by financing activities		1,595,500
Net increase (decrease) in cash and cash equivalents	(1,890,720)	105,135
Cash and cash equivalents at beginning of period	2,747,294	17,618
Cash and cash equivalents at end of period	856,574	122,753
Supplemental Disclosures of Cash Flow Information:
Cash paid during period for interest
Cash paid during period for taxes
Non-cash transactions:
Fair value of warrants issued for financing costs		217,971
Common stock issued in exchange for previously incurred debt	$ 4,022,000	$ 352,000